Symetryx Corp, 10% Owner at NeuBase Therapeutics, Inc. (NBSE), bought 122,152 shares at $0.98 ($120K) on 2023-09-01, disclosed to the SEC on 2023-09-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 61,076 | $60K | 50.0% |
| 2 | $0.98 | 61,076 | $60K | 50.0% |
| Total | $0.98 avg | 122,152 | $120K | 100% |
| Filing → |